Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från 2cureX via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Danmark |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-11-22 17:30:00
2cureX, a company pioneering the use of 3D tumoroids for drug sensitivity prediction in patients with cancer, will publish its Q3 2022 report on Thursday November 24, 2022 at 8:30 CET.
2cureX will host a webcast on the same day at 10:00 CET and present its Q3 results. After the presentation there will be a Q&A session at which 2cureX’s Executive Management will answer any questions to the Q3 reporting and to the Strategy Deep-Dive held on November 15, 2022.
To join the webcast, simply click here: https://www.2curex.com/2curex-webinar-q3-2022/
For editors and the press
For more information, please contact:
Fernando Andreu
Chief Executive Officer
fa@2curex.com